In times of crisis, adapting our programs to continue to serve you becomes our priority.

Make a donation

Friday, October 4 2019

Daratumumab (Darzalex) is Now Available in Newfoundland

As of Aug 16, 2019, Darzalex has been approved in Newfoundland, in combination with Lenalidomide and Dexamethasone, or Bortezomib and Dexamethasone for the treatment of patients with multiple myeloma with good performance status who have received at least one prior therapy.

More details